22 October – Webinar in connection with interim report
On 22 October 2026, Alligator hosted a webinar for investors, analysts and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the 2026 July-September interim report, which was followed by a Q&A session.
The call was held in English. A recording can be found following this link.
LATEST NEWS
Nomination Committee of Alligator Bioscience proposes new board and reduced fees ahead of extraordinary general meeting on 27 November 2026
Lund, 13 November 2026 – Alligator Bioscience AB (publ) The Nomination Committee of Alligator Bioscience AB (publ) (“Alligator&r …
Nomination Committee appointed in respect of AGM 2027 in Alligator Bioscience AB
Lund, Sweden, November 3, 2026 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that the Nomination Committee in prep …
Alligator Bioscience signs agreement to sell mitazalimab to Biossil
Lund, Sweden – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company whose principal asset is a financial interest i …
